Keytruda 100 MG/4 ML vial 4ML
Ended Awarded Last action
- Contract number
- SPE2DR26FSCA3
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $89,652
Award facts
- Contract value 100% obligated
- $89,651.53 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $89,651.53 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Keytruda 100 mg/4 mL vials. This firm fixed-price delivery order, issued on December 1, 2025, with an ultimate completion date of December 22, 2025, represents a single purchase under DMS Pharmaceutical Group's broader indefinite delivery contract with the Defense Logistics Agency. The award carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. Performance will take place at the contractor's headquarters in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) established under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, awarded on November 13, 2025, with a $500 million ceiling and completion date of December 31, 2036. The PPV-G GEN V represents a $30.3 billion acquisition strategy designed to provide the Department of Defense with a comprehensive pharmaceutical supply chain supporting military healthcare facilities globally. As one of multiple regional prime vendor contractors, DMS Pharmaceutical Group supplies branded and generic prescription medications, biologics, specialty pharmaceuticals, and medical consumables to meet the recurring medical supply needs of the federal military medical system, with this particular delivery order procuring oncology treatment inventory for DoD healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FSCA3?
SPE2DR26FSCA3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26FSCA3 worth?
The government has obligated $89,652 on SPE2DR26FSCA3.
Is contract SPE2DR26FSCA3 an order under another contract?
Yes. SPE2DR26FSCA3 is a delivery order under SPE2DR25D9316, an indefinite delivery contract.
Was contract SPE2DR26FSCA3 competed?
The extent of competition for SPE2DR26FSCA3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award